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Sera from patients with Lyme disease (LD) originating in the United States and Europe were
examined by western blot analysis for antibodies to LD spirochete components. Whereas some
components reacted with antibodies from the majority ofpatients, other componenits, notably
an abundant cellular protein with an apparent molecular weight of 34,000 were less commnonly
bound. This latter proteinaceous component was in a region of the polyacrylamide gel elec-
trophoresis profile which demonstrated variability between different LD spirochete isolates.
Thus, there may be more than one serotype of LD spirochete, and the 34,000-range proteins
may be a basis for such a distinction.
INTRODUCTION
The etiological agent of erythema chronicum migrans has been isolated and suc-
cessfully propagated in the laboratory [1-5]. Studies completed or under way will
tell us much about the metabolic requirements of the Lyme disease spirochete, its
ultrastructure, its susceptibility to antimicrobial agents, and its genetic relatedness to
other spirochetes. Nevertheless, we will probably still have much to learn ofhow this
previously unknown spirochete causes the skin lesion, the meningoencephalitis, the
cardiac abnormalities [6], and, perhaps most difficult to understand, the arthritis of
Lyme disease [7]. Although animal models of infection with this spirochete will be
of value in revealing the pathogenesis of Lyme disease, studies of the immune
response during human Lyme disease will provide complementary information.
METHODS
Techniques adapted from those of present-day basic biological research permit
figurative dissection ofthe Lyme disease spirochete into components and identifica-
tion ofwhich components patients form antibody against. One ofthese techniques is
the "western blot" (Fig. 1 schematically shows the western blot procedure). Cellular
proteins and some non-proteinaceous components are first separated, according to
their molecular weights, by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis [8]. The one-dimensionally separated components are then transferred
electrophoretically from the gel to nitrocellulose, yielding a replica ofthe gel pattern
on the nitrocellulose membrane matrix [9]. The unoccupied protein-binding sites on
the membrane are then "blocked" with an excess ofaglobular protein such as bovine
serum albumin. At this point, the "blot" is incubated with diluted antiserum or
hybridoma culture supernatants, washed to remove unbound antibody, and then
581
Address reprint requests to: Alan G. Barbour, M.D., LMSF, Rocky Mountain Laboratories, Hamil-
ton, MT 59840
Copyright t 1984 by the Yale Journal of Biology and Medicine, Inc.
All rights of reproduction in any form reserved.FIG. 1. Western blot procedure.
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probed for bound antibody with a reagent such as radioiodinated protein A. The
modifications ofthe western blot procedure used in the present studies have been de-
scribed elsewhere [10,11].
RESULTS
An early application of the western blot to the study of Lyme disease isshown in
Fig. 2. The patient, a resident of Shelter Island, NY (patient J.G. of[1]), had
erythema chronicummigrans, fever, myalgias, and malaise in June 1979. Blood was
drawn and the serum was saved. In April 1980, a convalescent specimen was ob-
tained and along with the acute illness serum was examined by western blot. Except
for the dark bands seen in both acute and convalescent sera blots at the top in area
of the stacking gel, only the convalescent serum showed evidence of having IgG an-
tibodies that bound to spirochete components.
An expanded western blot study was then undertaken at Rocky Mountain
Laboratories in collaboration with Drs. Allen Steere and Edgar Grunwaldt and with
the help ofseveral other investigators[11]. The results of this study showed that: (1)
There are several Ixodes dammini or Lyme disease spirochete components towhich
Lyme disease patients formed IgG antibody. (2) Sera from controls, including pa-
tients with clinically similar diseases such as rheumatoid arthritis, showed little reac-
tivity with these components. (3) There were some cross-reactivities between Lyme
disease spirochetes and other spirochetes demonstrated by western blots of Lyme
disease sera versus representatives of borrelia, treponemes, and leptospires and by
blots using sera obtained from patients with other spirochetal diseases such as sec-
ondary syphilis and relapsing fever.
One of the patients in this larger study was a woman who acquired Lyme disease
in Rhode Island and went on to develop chronic arthritis. The titer of antibodies in
both serum and synovial fluid to strain B31 of the L dammini spirochetes was
1:2,560 measured by indirect immunofluorescence [11]. The synovial fluid was ex-
amined by western blot for IgG antibodies to components of not only strainB3 1, a
cloned and many-passaged laboratory strain [2], but also to the original Shelter
Island tick isolate (IDS; [1]), from which B31 had been derived and which had been
passaged only three times before harvest for the studies, and to strain HBl9 [12]
isolated from the blood ofapatient with Lyme disease[3]. The western blot patterns
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FIG. 2. Western blot anialysis. Acute and convalescenit (conval.) sera from a resi-
denit of Shelter Island, NY, with Lyine disease (see text) was reacted with a whole cell
lysate of the originial Ixodes dammini spirochete (IDS) isolate from Shelter Islanld [1].
of this synovial fluid were, with the exception of differences in reactivities with a
very high molecular weight component and some low molecular weight components,
identical for the three isolates (Fig. 3). The pattern obtained with serum from this
patient was the same as that seen with synovial fluid (data not shown).
Notable in these blots are the reactions of antibodies not only with the ten com-
ponents previously identified [11] (and now denoted by their apparent molecular
weights) but also with an eleventh component with apparent molecular weight of 34
X 103 (34K). This was the same apparent molecular weight of an abundant protein
identified in the Coomassie brilliant blue-stained gel. The 34K molecular weight pro-
tein was in the region of the gel which has demonstrated variability between dif-
ferent strains [12]. A closer look at this part of the gel is shown in Fig. 4.
When the western blot patterns produced with sera from many Lyme disease pa-
tients were examined, however, I found that few sera had detectable antibodies to
components in the 34K region (Table 1). The sera used in this accounting were those
reported in [11] and samples from additional patients in the United States or
Europe. Each serum was drawn late in the course of or during convalescence from
an illness that by clinical criteria [13] was definite or probable Lyme disease. All sera
had indirect immunofluorescence titers aganist Lyme disease spirochetes of 1 to 80
or greater. In our laboratory, titers of 1 to 80 or greater were seldom found in sera
from controls [1,11; Barbour AG: unpublished observations].
When the sera were grouped with regard to continent of origin, six of 34 United
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FIG. 3. Western blot analysis of reactivities of
synovial fluid frompatient with chronicLymearthritis
(see text). Whole cell lysates of strains B31, IDS, and
^ 60 HBl9 were used. The relative mobilities of selected
46 - 46 components in the blots as well as in a Coomassiebril-
liant blue (CBB)-stained gel of strain B31 were deter-
mined bycomparison with themigrations of'4C-labeled
molecular weight standards (MWS). The MWS (with
3 1 lapparent molecular weights given in daltons x 103)
30- _29_ ---30 were phosphorylase B (93), bovine serum albumin (69),
t;-25 ovalbumin (46), carbonic anhydrase (30), and beta-
lactoglobulin (18). The apparent molecular weights of
11 components in the blots and in the gel are shown.
Differences between blots are seen near the top ofthe
c>- _--l f_ gel and in some components with apparent molecular
weights below 30 x 103.
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FIG. 4. Coom-assie brillianit blue-stainied proteinis of seveni Lyine disease spirochiete isolates
examiniied by PAGE. The regioni betweeni the molecular stanidards (MWS) of ovalbuminii (46)
anid carboniic anhlydrase (30)is shiown ini detail. The origini of the seveni isolates was described ini
[12]. Large arrows inidicate the regioni in the gel (arounid 34 x 103 daltonis) whiere variationi be-
tweeni strainis hias beeni noted. Straini B31 ini this gel was ani earlier passage of the sam-e straini
shiowni in Fig. 3. The closed trianigle inidicates a proteini in straini 50-2 that was niot detected ini
the othier isolates.IMMUNOCHEMICAL ANALYSIS
TABLE I
Presenice iil Westernl Blots of Detectable Banlds that Co-Migrated with
Lyme Disease Spirochete B31 Componienits
Source of Patienlt Seraa
Apparenit Molecular Uniited States Europe
Weight of Componienit (N = 34) (N = 9)
X 103) Number Positive (o) Number Positive (o)
17 20( 59) 1 ( 11)
25 15(44) 1(11)
29 22 ( 65) 3 (33)
31 13 (38) 1( 11)
34 6( 18) 0( 0)
41 34 (100) 7 ( 78)
60 33 ( 97) 9 (100)
61 27 ( 79) 4 (44)
66 31 ( 91) 1(11)
75 25 ( 74) 4 (44)
83 30 ( 88) 3 (33)
aPatienits with definiite or probable Lyme disease anid with serumn inldirect
immuinofluorescenice titers againist straini B31 of I to 80 or greater
States patients and none of the nine European patients were seen to have detectable
antibody to a 34K (or thereabouts) component. In contrast, components with ap-
parent molecular weights of 41K and 60K elicited antibodies from the majority of
patients from both the United States and Europe. The remaining componeints were
recognized by antibodies in a higher percentage of United States sera than in Euro-
pean sera.
DISCUSSION
A possible explanation for these results is that the 34K-range proteins are only
weakly immunogenic. Alternatively, ifthey are strongly immunogenic in their native
states, perhaps the immunodominant epitopes of the proteins are irreversibly altered
during the western blot procedures such that the majority of antibodies Ino lonlger
recognize them.
Although the western blot studies of serially obtained sera from several patients
with Lyme disease have clearly shown that there are individual differences in anti-
body responses to common components in the Lyme disease spiroclhetes [(1], the
finding that some patients, as well as rabbits infected with the spirochetes [1,11],
possess antibodies to a 34K component indicates that this component or componeints
are at least potentially immunogenic and that their epitopes are still intact after the
western blot procedures.
Thus, a more likely explanation, given the demonstrated variability between
strains in this region of the polyacrylamide gel profiles, for the infrequency of sera
showing reactivity to the 34K component is that there are different serotypes among
these spirochetes. A corollary of this conclusion is that the 34K proteins can perhaps
be used to distinguish between serotypes. Indeed, a monoclonal antibody that binds
in western blots to the 34K protein of strain B31 reacts in immunofluorescence
assays with this and other strains but not with several others [Barbour AG, Tessier
SL: Monoclonal antibodies in Lyme disease spirochetes. 1983. Twenty-tllird Inter-
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science Conference on Antimicrobial Agents and Chemotherapy. Abstract 239. Sub-
mitted for publication].
The failure to find evidence in European sera of any patients with antibodies to a
34K region component or of more than a few patients with antibodies to some other
components suggests that there may be differences in the distributions of various
serotypes between Europe and North America. Whether an inhomogenous
geographic distribution ofserotypes in any way results in dissimilarities between ixo-
did tick-associated syndromes on each side of the Atlantic, for example, in the ap-
parent lower frequency of arthritis in Europe [6,14], remains to be determined.
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